Studies of chitosan-Prussian blue nanozyme in auditory protection: from cellular mechanisms to in vivo validation
, suggesting that its combined ROS-scavenging and TLR4/NF-κB-modulating properties may represent a potential therapeutic strategy, pending further mechanistic and translational validation.
Authors
- Chunhuan Zhang (ORCID: https://orcid.org/0000-0002-6704-8098)
- Yan Qu
- Yong Li
- Yueyi Zhai
- Na Wang
- Peng Xie
- Pengcheng Ren
Institutions
- Hebei Medical University (CN)
- Third Hospital of Hebei Medical University (CN)
- North China University of Science and Technology Affiliated Hospital (CN)
- Hebei General Hospital (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-04-21
- DOI
- https://doi.org/10.3389/fimmu.2026.1758392
- Primary Topic
- Advanced Nanomaterials in Catalysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00